Bridgeway Capital Management’s Assembly Biosciences ASMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $276K | Hold |
15,225
| – | – | 0.01% | 884 |
|
|
2025
Q1 | $146K | Buy |
15,225
+1,200
| +9% | +$11.5K | ﹤0.01% | 982 |
|
|
2024
Q4 | $221K | Sell |
14,025
-475
| -3% | -$7.5K | 0.01% | 982 |
|
|
2024
Q3 | $220K | Hold |
14,500
| – | – | ﹤0.01% | 1042 |
|
|
2024
Q2 | $199K | Hold |
14,500
| – | – | ﹤0.01% | 1063 |
|
|
2024
Q1 | $193K | Hold |
14,500
| – | – | ﹤0.01% | 1114 |
|
|
2023
Q4 | $143K | Hold |
14,500
| – | – | ﹤0.01% | 1192 |
|
|
2023
Q3 | $154K | Hold |
14,500
| – | – | ﹤0.01% | 1143 |
|
|
2023
Q2 | $200K | Hold |
14,500
| – | – | ﹤0.01% | 1138 |
|
|
2023
Q1 | $146K | Sell |
14,500
-1,183
| -8% | -$11.9K | ﹤0.01% | 1164 |
|
|
2022
Q4 | $245K | Hold |
15,683
| – | – | 0.01% | 1034 |
|
|
2022
Q3 | $309K | Buy |
15,683
+1,183
| +8% | +$23.3K | 0.01% | 1028 |
|
|
2022
Q2 | $365K | Hold |
14,500
| – | – | 0.01% | 947 |
|
|
2022
Q1 | $358K | Buy |
14,500
+12,308
| +561% | +$304K | 0.01% | 1025 |
|
|
2021
Q4 | $61K | Hold |
2,192
| – | – | ﹤0.01% | 1238 |
|
|
2021
Q3 | $92K | Sell |
2,192
-3,141
| -59% | -$132K | ﹤0.01% | 1255 |
|
|
2021
Q2 | $248K | Sell |
5,333
-7,167
| -57% | -$333K | ﹤0.01% | 1235 |
|
|
2021
Q1 | $690K | Buy |
+12,500
| New | +$690K | 0.01% | 1000 |
|